NAA-004

N/A

Report date: 2025/06/05 16:57:55
NME

Base Information

Drug NameNAA-004
Drug Alias NameApazaNAA-004INN-108NOBEX-AA-004NM-004
ClassificationSmall molecules
Mechanisms of ActionNorepinephrine uptake inhibitorsCatenin beta 1 inhibitorsProtein phosphatase 2A inhibitors
TargetsNorepinephrine transporterCatenin beta 1Protein phosphatase 2A
Therapy Area/IndicationsInflammatory Bowel DiseasesColitis, UlcerativeGastrointestinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiocon Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies9 Meters Biopharma IncBiocon Ltd
Active IndicationsN/A
Inactive IndicationsInflammatory Bowel DiseasesColitis, UlcerativeGastrointestinal Diseases

Other Information

ATC CodeN/A
Related LinksN/A